infants of low birthweight than in mature infants (Chanarin, 1969) . Folate deficiency is the commonest cause of a megaloblastic anaemia in infancy (MacIver, 1962) , and premature babies tend to develop this anaemia at about 6 to 8 weeks of age, (Hoffbrand, 1970) . The serum and red cell folate levels have been shown to be related to dietary folate intake (Roberts et al., 1969) . Response to treatment is entirely satisfactory, but the need for prophylactic treatment of low birthweight infants is less well established. Folic acid supplements for premature babies have been advocated (Burland, Simpson, and Lord, 1971 ; Roberts et al., 1972) kg at birth, were entered in the trial and given a serial number. The nature and purpose of the trial was explained to the parents and their permission obtained. The serial numbers were notified to the hospital pharmacist who had previously allocated them at random to a 'treated' or a 'control' group. From the age of 2 weeks the 'treated' group received once daily a solution containing 50 ,ug folic acid in each dose, the 'control'
Received 15 February 1974. group received a similar volume of an inert liquid of identical appearance. The dropper bottles in which both solutions were dispensed were identified only by the infant's serial number. Only after the trial was completed did the pharmacist make known whether an infant had been receiving folic acid or the inert solution. All the infants were fed on reconstituted dried cow's milk, and semi-solids were added from the 2nd or 3rd month.
Each infant admitted to the trial was weighed and a specimen of blood was obtained by heel-stab. At the age of 1 month, and then at monthly intervals up to the age of 6 months, these examinations were repeated and the mother was asked if the baby had experienced any infections. On each specimen of blood the Hb, mean corpuscular volume (MCV), and red cell and serum folate levels were measured. Hb and red blood cell values were obtained by a Coulter S counter, serum and red blood cell folate levels were determined by an automated microbiological assay with Lactobacillus casei (Davis, Nicol, and Kelly, 1970) .
Due to failure of attendance, only 62 infants completed the trial, 29 in the treated group and 33 controls. Analysis was made of the results at 2 weeks, 4 months, and 6 months.
Results
Analysis of the treated and control group showed them to be of similar birthweight and gestational ages (Table I ). There were no significant differences in rate of growth between the two groups. At all ages the mean Hb levels were similar in the two groups (Table II) . The mean MCV of 105 fl was the same in the two groups at 2 weeks and at 4 months, but at 6 months the value in the control group was significantly higher (P > 0 * 05) than in the treated group. There was a significant negative correlation (P > 0 05) between MCV and red cell folate for the combined groups. When the treatment was begun at the age of 2 weeks, the mean serum folate level was higher in the control group than in the treated group. (Table  III) . The reason for this is not known but as allocation was random it must have been chance.
At 4 months and 6 months both serum and red cell folate levels were significantly higher in the treated group (P > 0 05). More infections were reported in the control group (21 %) than in the treated group (8%), but the difference did not reach a level of significance (Table IV) . 
Discussion A double-blind trial in infants has limitations due to dependence on maternal co-operation. Only a third of the babies who entered the trial could be followed up to the age of 6 months. Some of those who dropped out of the trial had died, some had developed conditions which necessitated their admission to hospital, some lived at a distance which made their regular attendance for follow-up very difficult, and some mothers withdrew their babies for domestic reasons. Thus, at the end of the trial we were left for analysis a selected group of babies who had no serious illness and whose mothers felt sufficiently concerned for their welfare to bring them for examination each month. In this selected series the only evidence consistent with folate deficiency in the control group was the significantly higher mean MCV at 6 months. This could be due to macrocytes formed between 2 weeks and 4 months remaining in the circulation. However, the mean serum and red cell folate of the untreated group were well within the accepted normal range and the Hb levels were similar to those in the treated group, at both 4 months and 6 months. Infections and gastrointestinal disturbances are factors in causing folate deficiency in low birthweight babies and conversely folate deficiency might be expected to predispose to infections, though no proof of this has been found. None of the infections occurring in the infants of this trial was severe. They were more frequent in the control group; the difference from the treated group did not, however, reach a level of significance. Further investigation with larger numbers might provide further evidence on this matter.
From an oral dose of 50 pug folic acid adequate absorption occurred, since at 4 months and 6 months both red cell and serum levels were significantly higher in the treated than in the control group, confirming the findings of Samuel, Burland, and Simpson (1973) 
